February 22, 2017 February 22, 2017 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis and HIV that also markets Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that Global Small Caps has initiated coverage of the Company including operations and overall shareholder value. The report is available at: http://tinyurl.com/NPHCreport

February 15, 2017 Nutra Pharma’s over the counter (OTC) products, Nyloxin® and Pet Pain-Away™, were featured on the NBC News Miami affiliate last night. February 15, 2017 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that the Company and their products were featured in an interview aired last night on Miami’s NBC News affil